HUBS vs SNDX · P/E 96, rev $1.79B vs rev $137.7M
HubSpot Inc (HUBS) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the HUBS and SNDX stock pages for the full models.
Not investment advice.